Results 211 to 220 of about 32,908 (264)
Some of the next articles are maybe not open access.
Dual antiplatelet therapy in the ‘real world’
Heart, 2018Dual antiplatelet therapy (DAPT) with aspirin and an oral P2Y12 inhibitor is a successful strategy for preventing recurrent ischaemic events following acute coronary syndromes (ACS). Clopidogrel was previously the P2Y12 inhibitor of choice but interpatient heterogeneity in levels of achieved platelet inhibition and delayed onset of action limit its ...
Eunice N C, Onwordi +2 more
openaire +2 more sources
Dual antiplatelet therapy duration
Current Opinion in Cardiology, 2011To address the evidence, or lack thereof, of dual antiplatelet therapy (DAPT) duration in the percutaneous coronary intervention (PCI) setting.The most recent guidelines on DAPT in the PCI setting are rather discordant about the duration of therapy and refer to results of studies which are often controversial.
Giuseppe, Musumeci +2 more
openaire +2 more sources
Exodontia in dual antiplatelet therapy: the evidence
British Dental Journal, 2016Haemostasis is crucial for the success of oral surgical treatment as bleeding problems can cause complications both pre- and post-operatively. Patients on antiplatelet drugs present a challenge due to their increased risk of bleeding.To identify a protocol for the management of oral surgery patients on dual antiplatelet therapy (aspirin and clopidogrel)
S, Nathwani, K, Martin
openaire +2 more sources
The Duel between Dual Antiplatelet Therapies
New England Journal of Medicine, 2013Current guidelines for patients who are being considered for percutaneous coronary intervention (PCI) recommend dual antiplatelet therapy (aspirin and a platelet adenosine diphosphate [ADP]–receptor antagonist) to minimize periprocedural complications.1 Clopidogrel is usually administered in patients with stable angina,2 whereas patients with an acute ...
Richard A, Lange, L David, Hillis
openaire +2 more sources
Dual antiplatelet therapy with clopidogrel and aspirin
American Journal of Health-System Pharmacy, 2008Dual antiplatelet therapy with clopidogrel and aspirin is reviewed.Several studies have evaluated the effectiveness of clopidogrel, aspirin, or the combination of these agents in a variety of patient populations. The results of these studies have helped determine the role of clopidogrel and aspirin in evidence-based medicine.
Joshua, Sullivan, Naseem, Amarshi
openaire +2 more sources